Caricamento...
Treating Parkinson’s disease by astrocyte reprogramming: Progress and challenges
Parkinson’s disease (PD), the second most prevalent neurodegenerative disorder, is typified by both motor and nonmotor symptoms. The current medications provide symptomatic relief but do not stimulate the production of new dopaminergic neurons in the substantia nigra. Astrocyte reprogramming has rec...
Salvato in:
| Pubblicato in: | Sci Adv |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Association for the Advancement of Science
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8221613/ https://ncbi.nlm.nih.gov/pubmed/34162545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abg3198 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|